Warning Letter points to ‘blurring of the lines’ between FDA & FTC
A Warning Letter from FDA telling the recipient to also respond to the FTC may indicate a ‘blurring of the lines between the two agencies’ laws and jurisdictions,’ says a FDA legal specialist.